NeuroMab™ Anti-EPHA2 BBB Shuttle Antibody(NRZP-1022-ZP3864)

Figure 1A is a graph showing the results of Western blotting showing whether an anti-EPHA2 antibody induces phosphorylation activity of EPHA2 tyrosine residues.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1A is a graph showing the results in the absence of a cross-linked antibody. The upper bar shows the results for the 4G10 antibody, and the lower bar shows the results for the anti-EPHA2 antibody (D7).

Figure 1B is a graph showing the Western blotting results of the presence or absence of the phosphorylation activity of EPHA2 tyrosine residues induced by anti-EPHA2 antibodies.

Fig. 1B is a graph showing the results in the presence of cross-linked antibodies, the upper part is the result of 4G10 antibody, and the lower part is the result of anti-EPHA2 antibody (D7).

Figure 2A is a graph showing the results of Western blot showing whether an anti-EPHA2 antibody has the activity of inducing a decrease in EPHA2 protein level.

Figure 2A is a graph representing the results obtained in the absence of cross-linked antibodies, wherein the upper column represents the results for the anti-EPHA2 antibody (D7) and the lower column represents the results for the anti-β-actin antibody.

Figure 2B is a graph showing the results of Western blot showing whether the anti-EPHA2 antibody has the activity of inducing the decrease of EPHA2 protein level.

Figure 2B is a graph showing the results in the presence of a cross-linked antibody, the upper column represents the results for the anti-EPHA2 antibody (D7), and the lower column represents the results for the anti-β-actin antibody;